|
PIERRE L. LeROY, M.D., F.A.C.S.
Neurological Surgery
and
Pain Management Consultant
September 19, 2001
Dr. Kirsch
Electromedical Products International, Inc.
2201 Garrett Morris Parkway
Mineral Wells, TX 76067
RE: Alpha-Stim Therapy
Dear Dr. Kirsch:
I wish to thank your
company, Electromedical Products International, Inc. for lending the Delaware
Pain Clinic program the FDA approved Alpha-Stim units for clinical trials to
evaluate and treat chronic, refractory neuropathic and myofacial pain
syndromes, without any financial interests.
Our limited trials of
ten patients who had both Somatic and Psychological diagnosis - were drug
free and provided informed consent agreements.
We were very impressed
they demonstrated significant clinical improvements. This group included
non-operative, pre-operative, and post-operative treatments.
The results were
encouraging enough to recommend a larger series for clinical trials in order
to accumulate more data, to better determine efficacy to avoid more complex
neuroaugmentive or ablative neurosurgical procedures by spinal and brain
stimulators, and trial of post-operative patients who have significant
residual pain syndromes as adjunctive therapy for those who are drug
sensitive or intolerant.
Could you please
organize a multi-center study for meta analysis?
Please advise me as
soon as possible.
Sincerely,
Pierre L. LeRoy, M.D.
Pierre L. LeRoy, M.D., F.A.C.S.
Newark Professional Center, 249 East Main Street, Newark,
Deleware 19711
Phone: (302) 736-9543, Fax: (302) 738-9508
|